Concepedia
Statistics
Publications
11
Citations
772
H-Index
Active since
2015
Affiliations
Roche (Switzerland)(Current)
Roche (United Kingdom)
The Royal Melbourne Hospital
Washington University in St. Louis
Peter MacCallum Cancer Centre
Emily Piccione is an author at Roche (Switzerland) specializing in immunology, medicine, and oncology.
Publications per year
2015–2023
A2AR Antagonism with CPI-444 Induces Antitumor Responses and Augments Efficacy to Anti–PD-(L)1 and Anti–CTLA-4 in Preclinical Models
Stephen B. Willingham, Po Y. Ho, Andrew Hotson et al. · Cancer Immunology Research · 2018 · 217 citations
Medicine, Immunology, Pharmacology +17
A bispecific antibody targeting CD47 and CD20 selectively binds and eliminates dual antigen expressing lymphoma cells
Emily Piccione, Silvia Juárez, Jie Liu et al. · mAbs · 2015 · 144 citations · Full text
Life Sciences, Immunology, Oncology +17
Pharmacodynamics and molecular correlates of response to glofitamab in relapsed/refractory non-Hodgkin lymphoma
Ann-Marie E Bröske, Koorosh Korfi, Anton Belousov et al. · Blood Advances · 2021 · 76 citations · Full text
Medicine, Oncology, Pharmacology +17
Loss of CD20 expression as a mechanism of resistance to mosunetuzumab in relapsed/refractory B-cell lymphomas
Stephen J. Schuster, Ling‐Yuh Huw, Christopher R. Bolen et al. · Blood · 2023 · 75 citations · Full text
Medicine, Immunology, Oncology +17
Glofitamab Step-up Dosing Induces High Response Rates in Patients with Hard-to-Treat Refractory or Relapsed Non-Hodgkin Lymphoma
Martin Hutchings, Carmelo Carlo‐Stella, Emmanuel Bachy et al. · Blood · 2020 · 56 citations
Medicine, Oncology, Pharmacology +11
1–5 of 11